Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujal Deshmukh

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Medicinal Chemistry|June 27, 2026
Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniquesJörg Berghausen, Ganesh Rajaraman, Sujal Deshmukh
Pharmaceutical Research|June 24, 2026
Utility of Relative Activity Factors to Determine Fraction Glucuronidation and Clearance of Icenticaftor in HumansMitesh Patel, Sahil Shaikh, Felix Huth, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Transplacental transfer and metabolism of buprenorphineTatiana Nanovskaya, Sujal Deshmukh, Monica Brooks, et al.
Pharmaceutical Research|August 6, 2024
Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTsSandhya Subash, Deepak Ahire, Mitesh Patel, et al.
Lab on a Chip|August 4, 2025
Utility of an <i>in vitro</i> lymphatics on-chip model for rank ordering subcutaneous absorption of monoclonal antibodiesAdriana Martinez Ledo, Gabriela Misiewicz, Thomas Dimke, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
The Journal of Biological Chemistry|December 2, 2010
Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitorKumiko Nagashima, Stuart D Shumway, Sriram Sathyanarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitorsJoshua Close, Richard Heidebrecht, John Hendrix, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Medicinal Chemistry|June 27, 2026
Enabling lead optimization with a focus on optimal dose selection by utilizing multi-parametric data visualization techniquesJörg Berghausen, Ganesh Rajaraman, Sujal Deshmukh
Pharmaceutical Research|June 24, 2026
Utility of Relative Activity Factors to Determine Fraction Glucuronidation and Clearance of Icenticaftor in HumansMitesh Patel, Sahil Shaikh, Felix Huth, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 26, 2001
Transplacental transfer and metabolism of buprenorphineTatiana Nanovskaya, Sujal Deshmukh, Monica Brooks, et al.
Pharmaceutical Research|August 6, 2024
Comparison of Relative Activity versus Relative Expression Factors (RAF versus REF) in Predicting Glucuronidation Mediated Drug Clearance Using Recombinant UGTsSandhya Subash, Deepak Ahire, Mitesh Patel, et al.
Lab on a Chip|August 4, 2025
Utility of an <i>in vitro</i> lymphatics on-chip model for rank ordering subcutaneous absorption of monoclonal antibodiesAdriana Martinez Ledo, Gabriela Misiewicz, Thomas Dimke, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of <i>N</i>-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
The Journal of Biological Chemistry|December 2, 2010
Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitorKumiko Nagashima, Stuart D Shumway, Sriram Sathyanarayanan, et al.
Bioorganic & Medicinal Chemistry Letters|April 10, 2012
Lead optimization of 4,4-biaryl piperidine amides as γ-secretase inhibitorsJoshua Close, Richard Heidebrecht, John Hendrix, et al.
Pageof 1